Epidemiology of chronic hepatitis B and C among dialysis patients in Switzerland;Epidemiologie der chronischen hepatitis B und C bei dialysepatienten in der Schweiz

Schweizerische Medizinische Wochenschrift

Volumn 130, Issue 10, 2000, Pages 341-348

  Ambuhl P M ^a   Binswanger, U ^a   Renner, E L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Chronic viral hepatitis; Epidemiology; Haemodialysis; Hepatitis B; Hepatitis C; Peritoneal dialysis; Switzerland

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ARTICLE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; PREVALENCE; SWITZERLAND;

HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; KIDNEY TRANSPLANTATION; PERITONEAL DIALYSIS; PREVALENCE; RENAL DIALYSIS; SWITZERLAND;

EID: 0034635780     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Harnett JD, Zeldis JB, Parfrey PS, Kennedy M, Sircar R, Steinmann TI, et al. Hepatitis B disease in dialysis and transplant patients. Further cpidemiologic and serologic studies. Transplantation 1987;44:3-76.
2. Chan TM, Lok AS, Cheng IK. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance hacmodialysis and continuous ambulatory pcritoneal dialysis. Nephrol Dial Transplant 1991;6:944-7.
3. Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis associated discases in the United States, 1995. ASAIO J 1998;44:98-107.
4. Vanderborght BO, Rouzere C. Ginuino CF, Macrtcns G, Heuverswyn HV, Yoshida CF. High prevalence of hepatitis C infection among Brazilian hcmodialysis patients in Rio de Janeiro: a one-year follow-up study. Rev lnst Med Trop Sao Paulo 1995;37:75-9.
5. Valderrahano F, Jones EH, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nephrol Dial Transplant 1995;1995(Suppl 5):l-25.
6. Pereira BJ, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997:51:981-99.
7. Kammerlander R. Anti-HCV Prävalenz bei schwangeren Frauen in der Schweiz. Personal communication 1999.
8. Renner EL. Anti-HCV Prävalcnz bei Stellungspflichtigen im Kanton Schaffhausen. Personal communication 1999.
9. Durand PY, Chanliau J, Gamberoni J, Hestin D, Kessler M. Prevalence and epidemiology of hepatitis C infection in patients on peritoneal dialysis in France: French PI centers. Adv Perit Dial 1996;12:167-70.
10. Tokars JI, Alter MJ, Favero MS, Moyer LA, Miller E, Bland LA. National surveillance of dialysis associated diseases in the United States, 1993, ASAIO J 1996;42:219-29.
11. Cendoroglo Neto M, Draibc SA, Silva AE, Ferraz ML, Granato C, Pereira CA, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among hacmodialysis and CAPI patients: evidence for environmental transmission. Nephrol Dial Transplant 1995;10:240-6.
12. Fujiyama S, Kwano S, Sato S, Shimada H, Matsushita K, Ikezaki N, et al. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff. Hepatogastroenterology 1995;42: 162-5.
13. Blumherg A, Zchnder C, Burckhardt JJ. Prevention of hepatitis C infection in haemodialysis units. A prospective study. Nephrol Dial Transplant 1995:10:210-1.
14. Pereira BJG, Natov SN, Bouthot BA, Murthy BV, Ruthazer R, Schmid CH, et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998;53:1374-81.
15. Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Dnrand D. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995;59:1426-31.
16. Krähenhühl S. Empfehlungen für die Therapie der chronischen Hepatitis B mit Interferon. Schwciz Ärztezeitung 1998; 79:2142-3.